To further understand how EJW improves AD symptoms at the lipid level, we examined mRNA expression of AGE, RAGE and NF-κB, linked to lipid metabolism, based on KEGG core target enrichment analysis results. The gene discussed is NFKB1; the disease is Alzheimer disease.